Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer
Reactive oxygen species in cancer progression and its role in therapeutics
Secondary bile acids, another important class of microbial products, have received attention for their ability to influence lipid metabolism and neuronal membrane homeostasis via receptors such as FXR and TGR5, thereby affecting amyloid processing and neuronal resilience in neurodegenerative conditions [146]
These effects are not the characteristics of a typical medication withdrawalinstead, they are the result of the body returning to its natural hormone levels
These findings demonstrate that CB0313.1 prevents high fat diet-induced obesity, and this effect may be associated with increased glucose, proteins oxidation and decreased fat oxidation
Most patients lose 15 to 20% of body weight over 6 to 12 months